Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism

Data evaluating the safety of using weight-based dosing of low-molecular-weight heparin (LMWH) in obese patients are limited. Some manufacturers have recommended a maximum daily dose of LMWH not to be exceeded. The purpose of this study was to determine if body weight influenced the anticoagulant re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pathophysiology of haemostasis and thrombosis 2001-01, Vol.31 (1), p.42-48
Hauptverfasser:	Wilson, S. Jo-Anne, Wilbur, Kerry, Burton, Erica, Anderson, David R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Original Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!